Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Wnts induce migration and invasion of myeloma plasma cells.

Qiang YW, Walsh K, Yao L, Kedei N, Blumberg PM, Rubin JS, Shaughnessy J Jr, Rudikoff S.

Blood. 2005 Sep 1;106(5):1786-93. Epub 2005 May 10.

2.

Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells.

Qiang YW, Yao L, Tosato G, Rudikoff S.

Blood. 2004 Jan 1;103(1):301-8. Epub 2003 Sep 22.

3.

Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism.

Kobune M, Chiba H, Kato J, Kato K, Nakamura K, Kawano Y, Takada K, Takimoto R, Takayama T, Hamada H, Niitsu Y.

Mol Cancer Ther. 2007 Jun;6(6):1774-84.

4.

Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.

Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr.

Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27.

PMID:
18294945
5.

Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.

Giuliani N, Morandi F, Tagliaferri S, Lazzaretti M, Donofrio G, Bonomini S, Sala R, Mangoni M, Rizzoli V.

Cancer Res. 2007 Aug 15;67(16):7665-74.

6.

Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.

Chim CS, Pang R, Fung TK, Choi CL, Liang R.

Leukemia. 2007 Dec;21(12):2527-36. Epub 2007 Sep 20.

PMID:
17882284
7.

Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.

Podar K, Tai YT, Lin BK, Narsimhan RP, Sattler M, Kijima T, Salgia R, Gupta D, Chauhan D, Anderson KC.

J Biol Chem. 2002 Mar 8;277(10):7875-81. Epub 2001 Dec 20.

8.

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells.

Derksen PW, Tjin E, Meijer HP, Klok MD, MacGillavry HD, van Oers MH, Lokhorst HM, Bloem AC, Clevers H, Nusse R, van der Neut R, Spaargaren M, Pals ST.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6122-7. Epub 2004 Apr 5.

9.

Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells.

Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, Nakazawa M, Yura Y.

Int J Oncol. 2010 Nov;37(5):1095-103.

PMID:
20878057
10.

Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.

Matsuoka H, Tsubaki M, Yamazoe Y, Ogaki M, Satou T, Itoh T, Kusunoki T, Nishida S.

Exp Cell Res. 2009 Jul 15;315(12):2022-32. doi: 10.1016/j.yexcr.2009.04.009. Epub 2009 Apr 22.

PMID:
19393235
11.

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.

Edwards CM, Edwards JR, Lwin ST, Esparza J, Oyajobi BO, McCluskey B, Munoz S, Grubbs B, Mundy GR.

Blood. 2008 Mar 1;111(5):2833-42. Epub 2007 Dec 19.

12.

[nm23-H1 gene inhibits lung cancer cell invasion through down-regulation of PKC signal pathway].

Nie Q, Zhou QH, Zhu W, Liu LX, Fu JK, Li DB, Li Y, Che GW.

Zhonghua Zhong Liu Za Zhi. 2006 May;28(5):334-6. Chinese.

PMID:
17044994
13.

Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.

Zuo Y, Wu Y, Chakraborty C.

J Cell Physiol. 2012 Apr;227(4):1399-407. doi: 10.1002/jcp.22853.

PMID:
21618528
14.
16.

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.

Qiang YW, Chen Y, Stephens O, Brown N, Chen B, Epstein J, Barlogie B, Shaughnessy JD Jr.

Blood. 2008 Jul 1;112(1):196-207. doi: 10.1182/blood-2008-01-132134. Epub 2008 Feb 27.

17.

Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro.

van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW.

Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):211-7.

18.

Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma.

Narayanan BA, Doudican NA, Park J, Xu D, Narayanan NK, Dasgupta R, Mazumder A.

Anticancer Res. 2012 Nov;32(11):4697-707.

19.

Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.

Parmo-Cabañas M, Molina-Ortiz I, Matías-Román S, García-Bernal D, Carvajal-Vergara X, Valle I, Pandiella A, Arroyo AG, Teixidó J.

J Pathol. 2006 Jan;208(1):108-18.

PMID:
16278822
20.

Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.

Zheng R, Iwase A, Shen R, Goodman OB Jr, Sugimoto N, Takuwa Y, Lerner DJ, Nanus DM.

Oncogene. 2006 Sep 28;25(44):5942-52. Epub 2006 May 1.

PMID:
16652149

Supplemental Content

Support Center